Month: May 2019

Johnson Controls announces cash tender offers for up to $1.5 billion in aggregate principal amount of senior notes PR Newswire CORK, Ireland, May 1, 2019 CORK, Ireland , May 1, 2019 /PRNewswire/ — Johnson Controls International plc (NYSE: JCI) today announced the commencement of tender offers (each, an “Offer,” and collectively, the “Offers”) to purchase for cash up to $1.5 billion in aggregate principal amount (as such amount may be increased by JCI pursuant to the terms of the Offers, the “Aggregate Maximum Purchase Amount”) of its 4.250% notes due 2021, 3.750% notes due 2021, 1.000% notes due 2023, 3.900% notes due 2026, 4.625% notes due 2023, 3.625% notes due 2024, 1.375% notes due 2025, 5.125% notes due 2045, 6.950% notes due 2045, 6.000% notes due 2036, 5.700% notes due 2041, 5.250% notes due 2041, 4.950% notes due 2064, 4.625% notes due 2044 and 4.500% notes due 2047. The terms and conditions of the Offers are set forth in JCI’s Offer to Purchase, dated May 1, 2019 (the “Offer to Purchase”). The Offer to Purchase relates to fifteen separate Offers, one for each series of notes and in the separate pools indicated in the tables below (each series, a “Series of Notes,” and such notes, collectively, the “Notes”). […]

Caris Life Sciences Acquires Pharmatech Purchase of leading Just-In-Time clinical trials recruitment service will benefit patients, physicians and drug developers by connecting cancer patients to the right trials faster PR Newswire IRVING, Texas, May 1, 2019 IRVING, Texas , May 1, 2019 /PRNewswire/ — Caris Life Sciences, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has acquired Pharmatech, Inc., a pioneer of the original Just-In-Time research system with the largest research-ready oncology network. With this strategic acquisition, Caris is changing the paradigm from the traditional physician outreach model to a real-time approach where patient identification is completed at the lab and the physician is informed so that the patient can be enrolled days earlier, and remain in the local physician’s care, without having to travel to a large central trial site. The acquisition promises to fundamentally redefine how pharmaceutical and biotechnology companies identify and rapidly enroll patients in precision oncology trials by combining Caris’ highest quality industry leading large-scale molecular profiling services with Pharmatech’s on-demand site activation and patient enrollment system. […]

CGI reports strong Q2 Fiscal 2019 results PR Newswire MONTRÉAL, May 1, 2019 Stock Market Symbols GIB.A (TSX) GIB (NYSE) cgi.com/newsroom Q2-F2019 results and year-over-year highlights Revenue of $3.1 billion , up 4.0% year-over-year or 4.7% in constant currency; Adjusted EBIT of $454.1 million , or 14.8% of revenue, up 40 basis points; Net earnings of $318.3 million , or 10.4% of revenue, up 110 basis points; Net earnings excluding specific items* of $324.5 million , or 10.6% of revenue, up 30 basis points; Diluted EPS of $1.14 , or $1.17 excluding specific items*, up 21.3% and 12.5% respectively; Cash provided by operating activities of $462.0 million or 15.1% of revenue, up $36.4 million ; Bookings of $3.3 billion in Q2, and $13.3 billion over the last twelve months, up $1.2 billion ; Book-to-bill of 106.1% in the quarter and 112.9% over the last twelve months; and, Backlog of $22.9 billion , up $897.9 million . *Specific items in Q2-F2019 include: $6.2 million in acquisition-related and integration costs net of tax; Specific items in Q2-F2018 include: $8.7 million in acquisition-related and integration costs and $20.1 million in restructuring costs both net of tax Note: All figures in Canadian dollars. […]

PeopleGrove Raises $4.7 Million in Series A Financing Round Led By Reach Capital PeopleGrove, an online platform that connects students with alumni and mentors before, during, and after university, has closed a $4.7 million Series A round of financing led by Reach Capital, with participation from Bisk Ventures, Collaborative Fund, GSV Acceleration, Launch Capital, Riverpark Ventures, and University Ventures. PR Newswire SAN FRANCISCO, May 1, 2019 SAN FRANCISCO , May 1, 2019 /PRNewswire-PRWeb/ — PeopleGrove, an online platform that connects students with alumni and mentors before, during, and after university, has closed a $4.7 million Series A round of financing led by Reach Capital, with participation from Bisk Ventures, Collaborative Fund, GSV Acceleration, Launch Capital, Riverpark Ventures, and University Ventures. At a time when universities need to serve an increasingly diverse range of students and demonstrate value, PeopleGrove provides the tangible support systems necessary for students to get the most from their educational experience and investment. […]

BASF and LetterOne Complete Merger of Wintershall and DEA – Creation of the largest independent oil and gas company in Europe – On track to reach production target of 750,000 to 800,000 barrels of oil equivalent per day between 2021- 2023, equivalent to an annual production growth rate of 6-8% – Synergies of at least €200 million per year – Initial Public Offering envisaged for 2nd half of 2020 PR Newswire LONDON, May 1, 2019 LONDON , May 1, 2019 /PRNewswire/ — LetterOne and BASF today announced the completion of the merger of their oil and gas businesses to create Wintershall Dea, the largest independent exploration and production company in Europe . All necessary regulatory approvals were received from nine countries, including Germany , Norway , the United Kingdom and Russia . […]